Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisMelphalanAntigens, CD34Blood Component RemovalHematologic NeoplasmsCombined Modality TherapyStem Cell TransplantationCyclophosphamideMultiple MyelomaGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem CellsBusulfanMyeloablative AgonistsBone Marrow TransplantationGraft SurvivalTreatment OutcomeStem CellsLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceIfosfamideCarmustineCord Blood Stem Cell TransplantationCytophagocytosisHematopoiesisSalvage TherapyVincristineAmyloidosisCytarabineTissue DonorsTransplantation ChimeraDisease-Free SurvivalHodgkin DiseaseRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationBlood CellsBlood Cell CountInfectionHistocompatibilityTime FactorsPlatelet CountPOEMS SyndromeSurvival AnalysisDoxorubicinHistocompatibility TestingLymphoma, T-CellImmunosuppressive AgentsVidarabineTransplantation, IsogeneicCarboplatinRecombinant ProteinsLeukemia, Myeloid, AcuteLeukocytes, MononuclearBone Marrow PurgingLeukemiaPrednisoneDexamethasoneLymphomaFollow-Up StudiesCytomegalovirus InfectionsImmunophenotypingFeasibility StudiesProspective StudiesAntineoplastic AgentsGraft vs Leukemia EffectFatal OutcomeBlood DonorsAnemia, AplasticT-LymphocytesBone MarrowMyelodysplastic SyndromesFlow CytometryCell SeparationLymphocyte DepletionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukocyte CountHematologic DiseasesHistiocytosis, Non-Langerhans-CellImmunomagnetic SeparationEmbryonic Stem CellsAntigens, CDBone Marrow DiseasesCells, CulturedOpportunistic InfectionsCyclosporineLivedo ReticularisHLA Antigens